TargetMol

Oxatomide

Product Code:
 
TAR-T19839
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T19839-1mg1mg£122.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T19839-5mg5mg£189.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T19839-10mg10mg£246.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T19839-25mg25mg£366.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T19839-50mg50mg£510.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T19839-100mg100mg£703.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T19839-500mg500mg£1,380.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Oxatomide is an H1 receptor antagonist. Oxatomide also has antiserotonergic actions.
CAS:
60607-34-3
Formula:
C27H30N4O
Molecular Weight:
426.564
Pathway:
Immunology/Inflammation|Membrane transporter/Ion channel|Metabolism|GPCR/G Protein|Neuroscience
Purity:
0.98
SMILES:
[O-]c1nc2ccccc2n1CCC[NH+]1CCN(CC1)C(c1ccccc1)c1ccccc1
Target:
Calcium Channel|Histamine Receptor|5-HT Receptor|P2X Receptor

References

1. Tobe M, Tsuboi K, Hasegawa F, Fujiwara N, Inoue Y, Isobe M, Isobe Y. Synthesis and biological evaluation of novel orally available 1-phenyl-6-aminouracils containing dimethyldihydrobenzofuranol structure for the treatment of allergic skin diseases. Bioorg Med Chem Lett. 2016 Feb 15;26(4):1292-5. doi: 10.1016/j.bmcl.2016.01.019. Epub 2016 Jan 8. PubMed PMID: 26786694. 2. Yoshida K, Ito M, Matsuoka I. P2X7 receptor antagonist activity of the anti-allergic agent oxatomide. Eur J Pharmacol. 2015 Nov 15;767:41-51. doi: 10.1016/j.ejphar.2015.10.002. Epub 2015 Oct 16. PubMed PMID: 26463039. 3. Raschi E, Poluzzi E, Salvo F, Koci A, Suling M, Antoniazzi S, Perina L, Hazell L, Moretti U, Sturkenboom M, Garbe E, Pariente A, De Ponti F. The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project. Drug Saf. 2016 Jan;39(1):59-68. doi: 10.1007/s40264-015-0353-1. PubMed PMID: 26446144; PubMed Central PMCID: PMC4712251. 4. Curtin Whelan L, Geary M, Sweetman P. Development and validation of a rapid liquid chromatographic method for the determination of oxatomide and its related impurities. J Chromatogr Sci. 2014 Nov-Dec;52(10):1267-72. doi: 10.1093/chromsci/bmt209. Epub 2014 Jan 27. PubMed PMID: 24474428.